Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-κB

INTRODUCTION: Nuclear factor κB (NF-κB) plays an important role in cancer progression and causes therapeutic resistance to chemotherapy. Pomalidomide, a third-generation immunomodulating drug derived from thalidomide, has been approved for uncontrolled multiple myeloma. We hypothesized that pomalido...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirai, Yoshihiro, Saito, Nobuhiro, Uwagawa, Tadashi, Shiba, Hiroaki, Horiuchi, Takashi, Iwase, Ryota, Haruki, Koichiro, Ohashi, Toya, Yanaga, Katsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880604/
https://www.ncbi.nlm.nih.gov/pubmed/29632644
http://dx.doi.org/10.18632/oncotarget.24577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880604/
https://www.ncbi.nlm.nih.gov/pubmed/29632644
http://dx.doi.org/10.18632/oncotarget.24577

Ejemplares similares